Achieving HCV Elimination in the United States: Progress and Next Steps

HCV Elimination 2019 Program Image
Download All
Expert faculty explore the necessary steps to achieve HCV elimination in this online educational program. Choose from 3 interactive video modules, 6 Webinars with accompanying downloadable audio and slidesets, and 3 ClinicalThought commentaries that discuss best practices in patient management for specific populations that are essential if HCV elimination is to be a feasible goal.
Mark S. Sulkowski, MD
Program Director
Matthew J. Akiyama, MD, MSc
Debra Newman, PA-C, MPAS, MPH
Anne Spaulding, MD, MPH

People Who Are Incarcerated

HCV elimination among incarcerated populations requires a comprehensive care strategy that includes harm reduction measures for people with substance use disorders, including provision of medication treatment for opioid use disorder. Here’s why.

Debra Newman, PA-C, MPAS, MPH Released: October 28, 2019

This downloadable slideset provides an examination of the burden of HCV in US correctional facilities; guidelines, challenges, and benefits of HCV screening in jails and prisons; the feasibility of HCV treatment in corrections; and strategies for improving linkage to HCV care upon community re-entry.

Matthew J. Akiyama, MD, MSc Released: October 8, 2019

This interactive video module provides in-depth expert analysis of the barriers impeding expanded diagnosis, treatment, and cure of HCV infection among individuals who are incarcerated in jails or prisons along with important insights on critical strategies needed to overcome these challenges.

Mark S. Sulkowski, MD
Program Director
Matthew J. Akiyama, MD, MSc Debra Newman, PA-C, MPAS, MPH Anne Spaulding, MD, MPH
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 6, 2019 Expired: No longer available for credit

This downloadable slideset provides a review of challenges to eliminating HCV infection among people who are incarcerated and models of care seeking to overcome these barriers.

Matthew J. Akiyama, MD, MSc Debra Newman, PA-C, MPAS, MPH Anne Spaulding, MD, MPH Released: June 6, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provides insights on guidelines, challenges, and benefits of HCV screening in jails and prisons; the feasibility of HCV treatment in corrections; and strategies for improving linkage to HCV care upon community re-entry.

Matthew J. Akiyama, MD, MSc Released: October 10, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provides insights on strategies to make HCV treatment in correctional settings more accessible and the critical role of harm reduction in preventing ongoing HCV transmission.

Anne Spaulding, MD, MPH Released: October 31, 2019

This downloadable slideset reviews the critical challenge of addressing HCV in correctional facilities to reach HCV elimination goals in the United States as well as mechanisms for overcoming identified barriers, including a simplified HCV assessment and treatment algorithm facilitating HCV management for the majority of patients in almost any healthcare setting, including correctional health, and important mechanisms that have been implemented or proposed to overcome treatment access barriers for people who are incarcerated.

Anne Spaulding, MD, MPH Released: October 24, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue